Want to see CVSA full AI Analyst Report?
CVSA Stock Chart & Stats
$115.84
$3.59(3.10%)
At close: 4:00 PM EDT
$115.84
$3.59(3.10%)
Day’s Range― - ―
52-Week Range$86.97 - $156.26
Previous CloseN/A
Volume76.09K
Average Volume (3M)367.02K
Market Cap
$4.50B
Enterprise Value$4.82K
Total Cash (Recent Filing)$406.32M
Total Debt (Recent Filing)$905.50M
Price to Earnings (P/E)17.4
Beta0.70
Next Earnings
Oct 29, 2026EPS Estimate
1.84Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)7.62
Shares Outstanding34,038,820
10 Day Avg. Volume376,642
30 Day Avg. Volume367,016
Financial Highlights & Ratios
PEG Ratio1.20
Price to Book (P/B)3.02
Price to Sales (P/S)2.24
P/FCF Ratio11.12
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$166.00Price Target Upside43.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)8.89
Revenue Forecast (FY)$2.07B
Bulls Say, Bears Say
Bulls Say
Enrollment MomentumSustained multi-quarter enrollment gains across the platform demonstrate durable demand for Covista’s programs and strengthen revenue visibility. Consistent student intake supports scale economics in instruction and margins, making future revenue growth less dependent on one-off promotions or temporary market cycles.
High Operating Margins & ScaleStrong TTM margins and positive net income reflect scalable delivery and pricing power in education services. Elevated gross and EBITDA margins provide persistent cash generation potential and buffer against cyclical enrollment dips, supporting reinvestment and strategic expansion over the medium term.
Improving Cash & Leverage PositionRising free cash flow and lower net leverage increase financial flexibility to fund campus growth, tech investments, and buybacks. A lower cost, extended maturity on the term loan reduces interest risk and supports durable capital allocation choices without immediate strain on operating cash.
Bears Say
Margin VolatilityObserved swings in net margins and a prior-year loss highlight operating sensitivity to calendar timing, program mix and reinvestment. Persistent margin variability raises execution risk and could compress returns if competitive pricing or investment requirements intensify during the expansion of campuses and programs.
Upward Drift In Absolute DebtAlthough leverage remains moderate, rising absolute debt reduces flexibility if earnings weaken. An upward trend in debt elevates refinancing and interest-rate sensitivity over time, limiting room for opportunistic investments or insulating the business during slower enrollment or margin compression periods.
Cash-Conversion & Investment PressureOperating cash flow trailing net income and prior periods of weak free cash flow indicate working-capital and timing risks. Management also flagged a near-term CapEx and strategic investment ramp, which could further pressure cash conversion and constrain discretionary spending until new programs scale.
Covista News
CVSA FAQ
What was Covista Inc.’s price range in the past 12 months?
Covista Inc. lowest stock price was $86.97 and its highest was $156.26 in the past 12 months.
What is Covista Inc.’s market cap?
Covista Inc.’s market cap is $4.50B.
When is Covista Inc.’s upcoming earnings report date?
Covista Inc.’s upcoming earnings report date is Oct 29, 2026 which is in 71 days.
How were Covista Inc.’s earnings last quarter?
Covista Inc. released its earnings results on Aug 06, 2026. The company reported $2.09 earnings per share for the quarter, beating the consensus estimate of $1.892 by $0.198.
Is Covista Inc. overvalued?
According to Wall Street analysts Covista Inc.’s price is currently Undervalued.
Does Covista Inc. pay dividends?
Covista Inc. pays a Semiannually dividend of $0.18 which represents an annual dividend yield of N/A. See more information on Covista Inc. dividends here
What is Covista Inc.’s EPS estimate?
Covista Inc.’s EPS estimate is 1.84.
How many shares outstanding does Covista Inc. have?
Covista Inc. has 34,038,820 shares outstanding.
What happened to Covista Inc.’s price movement after its last earnings report?
Covista Inc. reported an EPS of $2.09 in its last earnings report, beating expectations of $1.892. Following the earnings report the stock price went up 13.456%.
Which hedge fund is a major shareholder of Covista Inc.?
Currently, no hedge funds are holding shares in CVSA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Covista Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$166.00 (43.30% Upside)
$166.00 (43.30% Upside)
Blogger Sentiment
Bullish
CVSA Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 51.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.5%
Last 30 Days ▲ 1.6%
Last 30 Days ▲ 1.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.43%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
13.76%
Trailing 12-Months
Company Description
Covista Inc.
Adtalem Global Education, Inc. is an enterprise dedicated to providing higher education. The company organizes its operations into three primary divisions: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment delivers various degree and non-degree offerings within the nursing and broader health professions higher education sector. Through its Walden segment, the company offers extensive online learning options, including certificates, bachelor's, master's, and doctoral degrees in a wide range of subjects such as nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. The Medical and Veterinary division provides both degree-granting and non-degree curricula tailored for post-secondary education in medicine and veterinary sciences. Dennis J. Keller and Ronald L. Taylor established the company in 1973, and its corporate headquarters are situated in Chicago, Illinois.
CVSA Company Deck
CVSA Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial momentum: enrollment growth across institutions, improved margins (when adjusting for a one-week timing shift), raised revenue and EPS guidance, robust free cash flow, balance sheet improvement, share repurchases, campus expansion plans, and technology/AI initiatives. Near-term headwinds include an $18M timing impact at Walden that masked stronger underlying results, modest absolute enrollment improvement at Chamberlain this quarter (0.5%), continued investment-driven CapEx and strategic spending, and an expected higher effective tax rate. Overall, the positives (organic growth, margin expansion excluding timing, raised guidance, cash generation, and clear remediation at Chamberlain) outweigh the transitory and execution-related challenges noted.View all CVSA earnings summariesCVSA Stock 12 Month Forecast
Average Price Target
$166.00
▲(43.30% Upside)
Technical Analysis
Perdoceo Education
―
Grand Canyon Education
―
Strategic Education
―
Graham Holdings
―
Laureate Education
―
Ownership Overview
2.68% Insiders
40.56% Mutual Funds
21.25% Other Institutional Investors
7.16% Public Companies and
Individual Investors